SCHEMBL1442147

SCHEMBL1442147

COc1cccc(-c2ccc3ncc(N4CCOCC4)nc3c2)c1.Clc1ccc(-c2ccc3ncc(N4CCOCC4)nc3c2)c(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.49
▸ CYP1A2 P05177 3/20 0.49
▸ TSHR P16473 3/20 0.49
▸ CYP3A4 P08684 2/20 0.49
▸ CYP2C19 P33261 2/20 0.49
▸ USP2 O75604 2/20 0.49
▸ HIF1A Q16665 2/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ CLK4 Q9HAZ1 1/20 0.49
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ MAPT P10636 3/20 0.47
▸ CNR2 P34972 2/20 0.46
▸ CYP2C9 P11712 1/20 0.44
▸ STK4 Q13043 1/20 0.44
▸ STK3 Q13188 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1442929 0.92 ALDH1A1 (0.49) ALDH1A1CYP1A2TSHRCYP3A4CYP2C19
SCHEMBL12812381 0.89 ALDH1A1 (0.60) ALDH1A1CYP1A2TSHRCYP3A4CYP2C19
SCHEMBL12812382 0.88 CNR2 (0.54) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL27882012 0.83 MEN1 (0.47) ALDH1A1CYP1A2TSHRCYP3A4CYP2C19
SCHEMBL10179693 0.83 ALDH1A1 (0.51) ALDH1A1CYP1A2TSHRCYP3A4CYP2C19
SCHEMBL1443473 0.81 CNR2 (0.67) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL12811769 0.81 TNIK (0.55) ALDH1A1CYP1A2TSHRCYP3A4CYP2C19
SCHEMBL13276521 0.80 ALDH1A1 (0.60) ALDH1A1CYP1A2TSHRCYP3A4CYP2C19
SCHEMBL13276777 0.80 ALDH1A1 (0.57) ALDH1A1CYP1A2TSHRCYP3A4CYP2C19
SCHEMBL1443214 0.80 ALDH1A1 (0.52) ALDH1A1CYP1A2TSHRCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2473498-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS Bayer Pharma Aktiengesellschaft (DE) 2012-07-11 — — EP claimed
WO-2011026579-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-10 — — WO claimed
Send feedback